Bolt Biotherapeutics, Inc. - Common Stock — Bilancio Trimestrale (NASDAQ:BOLT) | MetaTrader

Apri il grafico completo Full chart

Notizie

Rodman & Renshaw avvia copertura di Bolt Biotherapeutics con rating buy

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Lags Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates

Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?

Il CEO di Bolt Biotherapeutics Quinn acquista azioni per 686 dollari

Nemec, SVP di Bolt Biotherapeutics, acquista azioni per 686 dollari

Bolt Biotherapeutics CEO Quinn buys shares worth $686

Nemec, Bolt Biotherapeutics SVP, acquired shares worth $686

Azioni Bolt Biotherapeutics: iniziata copertura con rating Buy da H.C. Wainwright

Bolt Biotherapeutics stock initiated with Buy rating at H.C. Wainwright

Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Mr. Cooper Gr (NASDAQ:COOP), Bolt Biotherapeutics (NASDAQ:BOLT)